Pituitary Insufficiency Diagnosed After Coronavirus Disease-19: A Case Report

Kaya M. G., Ertürk C., Güven M.

ERCIYES MEDICAL JOURNAL, cilt.44, sa.3, ss.347-349, 2022 (ESCI)

  • Yayın Türü: Makale / Vaka Takdimi
  • Cilt numarası: 44 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.14744/etd.2021.30676
  • Dergi Adı: ERCIYES MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.347-349
  • Lokman Hekim Üniversitesi Adresli: Evet

Özet

Background: Severe acute respiratory syndrome-coronavirus (SARS-CoV) and SARS-CoV-2 might affect the hypothalamic-pituitary-adrenal axis. This paper presents a rare case of pituitary insufficiency diagnosed after CoV disease (COVID)-19. Case Report: On December 7, 2020, a 67-year-old male patient presented to the Endocrinology Department of Lokman Hekim University with weakness, weight loss, and abdominal pain lasting for 3 weeks. In his medical history, he had a positive real-time polymerase chain reaction test result for SARS-CoV-2 based on the nasopharyngeal swab analyzed on September 30. Central hypothyroidism, secondary adrenal insufficiency, hypogonadotropic hypogonadism, and a low dehydroepiandrosterone-sulfate level were detected in the laboratory examinations. Steroid therapy was initiated. Conclusion: Non-specific adrenal insufficiency symptoms such as fatigue and weakness, and psychosomatic symptoms can be seen during the course of COVID-19 or the post-COVID-19 period. Physicians should be aware about the systemic effects of SARS-CoV-2 infection and follow-up patients with a history of COVID-19 accordingly